Cosmetic Results With Tissue Adhesive vs. Subdermal Sutures in Cesarean Section
ADTID
1 other identifier
interventional
36
1 country
1
Brief Summary
Morbidity associated with post-cesarean wound closure, including cosmetically unfavorable scarring, is a significant concern in obstetrics, impacting patient satisfaction and recovery. Recent advances have introduced the use of tissue adhesives, such as 2-octylcyanoacrylate, which promise to improve cosmetic outcomes and reduce postoperative complications. This study will evaluate different tissue adhesive application schedules, keeping the total dose constant, to determine whether the method of application influences cosmetic results and the incidence of postoperative complications
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 30, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedFirst Posted
Study publicly available on registry
January 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedFebruary 17, 2026
January 1, 2025
7 months
December 30, 2024
February 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in the OSAS Scale score
The OSAS score is based on the assessment of several aspects of a scar, and each of these aspects is scored individually. Each variable uses a 10-point scoring system, where 1 represents normal foot. The scores of the individual variables can be added together to obtain a total score ranging from 5 to 50, where 5 represents normal skin. Items typically assessed include: * Vascularity: Refers to the presence of visible blood vessels or red coloration in the scar. * Pigmentation: Assesses whether the scar has a different color than the surrounding skin. * Thickness: Refers to the height or prominence of the scar above the level of the surrounding skin. * Relief: Assesses the texture of the scar compared to the surrounding skin. * Flexibility: Measures how stiff or flexible the scar is compared to the surrounding skin.
One month from the first intervention until 6 months
Secondary Outcomes (1)
PSAS scale score
One month from the first intervention until 6 months
Study Arms (2)
Intervention
EXPERIMENTALuse 2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incision
Control
ACTIVE COMPARATORwound closure with subdermal sutures using 2-0 nylon thread
Interventions
2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incision
wound closure with subdermal sutures using 2-0 nylon thread, under the same evaluation scheme
Eligibility Criteria
You may qualify if:
- Submission of a signed and dated informed consent form.
- Declared willingness to comply with all study procedures and availability for the duration of the study.
- Pregnant patient at 37 or more weeks gestation, scheduled for elective cesarean section at the Hospital Materno Infantil.
- Cesarean section performed in the Maternity and Children's Hospital, operating room.
- Literate patient, able to understand and respond to the study questions, with body mass index less than 30.
- Possess cell phone or other means of communication to facilitate postoperative follow-up.
- Residing in the city of Tegucigalpa, Honduras, to ensure accessibility to scheduled follow-up visits.
You may not qualify if:
- Patients under 18 years of age.
- Patients with diagnosed psychiatric illnesses that may interfere with their ability to give informed consent or follow the study protocol.
- Pregnant patients with complications that may affect the healing process or increase the risk of postoperative complications, such as severe preeclampsia.
- Diabetes.
- Collagen diseases.
- Autoimmune diseases (rheumatoid arthritis, Crohn's disease).
- Vascular diseases (vasculitis).
- Coagulation disorders (thrombophilia).
- Pregnant patients with premature rupture of membranes, since this may influence the choice of timing and method of cesarean section.
- Pregnant patients diagnosed with chorioamnionitis, which represents an increased risk of postoperative infection.
- Pregnant patients diagnosed with acute abdomen, which may require emergency surgical management that is not compatible with standard cesarean section procedures.
- Pregnant patients with multiple pregnancies, since this could complicate the cesarean section procedure and affect the results of the study.
- Presence of major fetal malformations that may require additional interventions at birth.
- Fetal stillbirth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Escuela
Tegucigalpa, Francisco Morazán Department, 11101, Honduras
Related Publications (1)
Cromi A, Ghezzi F, Gottardi A, Cherubino M, Uccella S, Valdatta L. Cosmetic outcomes of various skin closure methods following cesarean delivery: a randomized trial. Am J Obstet Gynecol. 2010 Jul;203(1):36.e1-8. doi: 10.1016/j.ajog.2010.02.001. Epub 2010 Apr 24.
PMID: 20417924BACKGROUND
Study Officials
- STUDY DIRECTOR
Ricardo A. Gutierrez Ramirez, MD, MSc
Universidad Nacional Autonoma de Honduras
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Both the patient and the principal investigator will know the intervention, the data analyst researcher does not know the group to which the patients have been assigned.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Titular professor
Study Record Dates
First Submitted
December 30, 2024
First Posted
January 6, 2025
Study Start
January 1, 2025
Primary Completion
July 31, 2025
Study Completion
December 30, 2025
Last Updated
February 17, 2026
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
It is not necessary, none of the 18 HIPAA identifiers will be placed